Alex Goldberg

NASDAQ Decliners Watch List: Windstream Holdings, Inc. (NASDAQ:WIN) and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Added to Equity Profile Report's NASDAQ Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/03/2014 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Windstream Holdings, Inc. (NASDAQ:WIN) and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN).

Windstream Holdings, Inc. (NASDAQ:WIN) a company that provides communications and technology solutions in the United States is currently down (-3.21%) on 8,679,749 shares traded as Windstream will hold a conference call on Feb. 27 to review the company's fourth-quarter and full-year 2013 earnings results. Windstream Holdings, Inc. (NASDAQ:WIN) is currently down (-26.97%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Windstream Holdings, Inc. (NASDAQ:WIN)

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) a biopharmaceutical company that develops and commercializes life-transforming therapeutic products is currently down (-2.85%) on 1,474,380 shares traded after TheStreet Quant Ratings rated Alexion Pharmaceuticals as a buy. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is currently down (-9.71%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com